|
NUDT17 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.830500E-02 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.847450E-01 |
| Normal-vs-Stage2 |
1.677790E-01 |
| Normal-vs-Stage3 |
2.500400E-01 |
| Normal-vs-Stage4 |
3.905600E-01 |
| Stage1-vs-Stage2 |
4.837400E-01 |
| Stage1-vs-Stage3 |
7.383600E-01 |
| Stage1-vs-Stage4 |
6.504000E-01 |
| Stage2-vs-Stage3 |
7.378800E-01 |
| Stage2-vs-Stage4 |
8.777400E-01 |
| Stage3-vs-Stage4 |
9.140600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.357900E-02 |
| Normal-vs-AfricanAmerican |
2.834400E-01 |
| Normal-vs-Asian |
6.447800E-01 |
| Caucasian-vs-AfricanAmerican |
3.210400E-01 |
| Caucasian-vs-Asian |
9.993600E-01 |
| AfricanAmerican-vs-Asian |
8.471000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.572020E-01 |
| Normal-vs-Female |
8.822500E-03 |
| Male-vs-Female |
5.888000E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
6.074000E-02 |
| Normal-vs-Extreme_Weight |
2.142000E-01 |
| Normal-vs-Obese |
5.703700E-02 |
| Normal-vs-Extreme_Obese |
6.767800E-01 |
| Normal_Weight-vs-Extreme_Weight |
2.863400E-01 |
| Normal_Weight-vs-Obese |
7.390200E-01 |
| Normal_Weight-vs-Extreme_Obese |
4.159000E-01 |
| Extreme_Weight-vs-Obese |
3.551000E-01 |
| Extreme_Weight-vs-Extreme_Obese |
6.979800E-01 |
| Obese-vs-Extreme_Obese |
4.532200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.264600E-01 |
| Normal-vs-Age(41-60Yrs) |
1.658420E-02 |
| Normal-vs-Age(61-80Yrs) |
3.411400E-01 |
| Normal-vs-Age(81-100Yrs) |
3.927200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.006600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.641600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.964200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.733600E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.394000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.956800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
4.707800E-02 |
| Normal-VS-Type2 PRCC |
3.768200E-02 |
| Normal-VS-KIRP CIMP |
4.255600E-02 |
| Normal-VS-Unclassified PRCC |
2.553800E-02 |
| Type1 PRCC-VS-Type2 PRCC |
4.737800E-01 |
| Type1 PRCC-VS-KIRP CIMP |
6.371600E-04 |
| Type1 PRCC-VS-Unclassified PRCC |
2.452800E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.627990E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
6.079200E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
7.441300E-03 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.538800E-01 |
| Normal-vs-N1 |
2.034200E-01 |
| Normal-vs-N2 |
3.374400E-01 |
| N0-vs-N1 |
3.857000E-01 |
| N0-vs-N2 |
2.494600E-01 |
| N1-vs-N2 |
2.968400E-01 |
|
|
